esc semaglutide Novo Nordisk to Share Heart Data at 2025 Design and Baseline Characteristics of

reported that during rapid freezing, small, iced crystals can form that can minimise disruption of the bilayer structure

Key efficacy results: - Up to 12.2% weight loss from baseline (26.6 lbs) at the highest dose - Up to 10.9% placebo-adjusted weight loss - Statistically significant, dose-dependent weight loss across all dose cohorts - Weight loss was progressive from Week 1 through Week 13 with no plateau observed - Significant differences versus placebo were observed for all doses above 15 mg starting at Week 1 Why "no plateau" matters: Most GLP-1 drugs show a weight loss plateau at some point the body adapts and weight loss slows

For early to moderate osteoarthritis, yes it may delay or avoid surgery

Signs your medication may have degraded include cloudiness, particles floating in the solution, or discoloration